# Glucose Health, Inc. (GLUC)

> Consumer Defensive · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/GLUC/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 98.7K | $ -469.6K | $ -159.1K | $ 4.3K | $ 73.6K |
| 2025 | $ 348.8K | $ -232.5K | $ -16.2K | $ 0 | $ 146.8K |
| 2024 | $ 403.7K | $ -332.1K | $ -487.6K | $ 234.4K | $ -65.0K |
| 2023 | $ 578.2K | $ -456.2K | $ -261.2K | $ 0 | $ 257.7K |
| 2022 | $ 1.08M | $ -812.2K | $ -416.9K | $ 0 | $ 577.1K |
| 2021 | $ 1.13M | $ -208.2K | $ -86.0K | $ 0 | $ 1.04M |
| 2018 | $ 141.5K | $ 3.9K | $ 4.6K | $ 431.3K | $ -376.0K |
| 2017 | $ 98.3K | $ 52.6K | $ -18.7K | $ 332.9K | $ -426.2K |
| 2016 | $ 430.9K | $ -552.4K | $ -54.0K | $ 351.8K | $ -495.4K |
| 2015 | $ 6.0K | $ -373.6K | $ -162.6K | $ 308.3K | $ -387.8K |
| 2014 | $ 3.9K | $ -945.9K | $ -191.3K | $ 169.9K | $ -280.6K |
| 2013 | $ 30.9K | $ -2.08M | $ -187.7K | $ 78.7K | $ -197.8K |
| 2012 | $ 0 | $ -576.2K | $ -120.8K | $ 60.7K | $ 22.2K |
| 2011 | $ 0 | $ -1.32M | $ -34.2K | $ 77.0K | $ -186.0K |
| 2010 | $ 3.6K | $ -958.1K | $ -166.0K | $ 293.0K | $ -594.6K |
| 2009 | $ 46.1K | $ -1.39M | $ -159.0K | $ 121.3K | $ -301.1K |
| 2008 | $ 78.2K | $ -801.4K | $ -298.9K | $ 39.0K | $ 25.6K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.06 |
| Liabilities / Eq | 2.35 |
| Current Ratio | 1.33 |

## Other views

- [Metrics](https://sponda.capital/en/GLUC.md)
- [Charts](https://sponda.capital/en/GLUC/charts.md)
- [Compare](https://sponda.capital/en/GLUC/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.